The Bioverge Podcast: Reengineering Healthcare and Medicine with Technology

Vineeta Agarwala, General Partner at Andreessen Horowitz and lead of the firm’s bio and health fund, sits down with Neil to discuss her investment process, how technology is transforming biotech and healthcare, and why she thinks drug development becoming more and more like software development.

continue reading >

The Bioverge Podcast: Unlocking the Potential of Genetic Medicines

David Kirn, Co-Founder and CEO of 4DMT, sits down with Neil to discuss the limits of existing AAV vectors and how his company is using its Therapeutic Vector Evolution platform to invent customized vectors that allows it to take a disease specific approach to unlock the potential of genetic medicines.

continue reading >

Neil Littman on The Scaling Up Podcast - Investing in the Future of Health

Neil is the Founder & CEO of Bioverge Ventures, an investment platform democratizing access to enable individuals to diversify their portfolio with private biotech and healthcare investments for the purposes of long-term wealth creation.

continue reading >

JelikaLite: A Home-Based, Non-Invasive Therapy for Children with Autism

JelikaLite has developed the first home-based, non-invasive stimulation device for children with autism. Known as Cognilum, it combines a wearable neurostimulation and EEG-sensing device with an AI-driven data platform in an integrated system to analyze developmental trajectory and personalize future treatments in a feedback loop.

continue reading >

The Bioverge Podcast: Making Medicines Affordable For Everyone

Peter Kolchinsky, Founder and Managing Director of RA Capital Management and Founder of the nonprofit No Patient Left Behind, sits down with Neil to discuss his book “The Great American Drug Deal,” policy fights over pricing, and his organization’s efforts to make medicines affordable for all Americans.

continue reading >

The Bioverge Podcast: Unleashing the Power of Gene Therapy for a Broad Universe of Diseases

Kriya Therapeutics Co-Founder, Chairman, and CEO Shankar Ramaswamy sits down with Neil to discuss how the company is changing the way gene therapies are designed, developed, and manufactured in an effort to cut costs, accelerate the time to market, and expand the reach of gene therapy to a broad universe of disease.

continue reading >

The Bioverge Podcast: A Bioinformatician Turned Investor Seeks to Transform Drug Development with Technology

Francisco Gimenez, Partner at 8VC, sits down with Neil to discuss how his background in data science and bioinformatics shapes his investment approach and the potential to transform drug development with technology.

continue reading >

The Bioverge Podcast: A Rockstar Investor Who Backs Transformational Technologies

D.A. Wallach sits down with Neil to discuss his journey from recording artists to venture investors, his co-founding of Time BioVentures, and his vision from transforming biotechnology and healthcare with technology.

continue reading >

The Bioverge Podcast: Harnessing CRISPR to Cure Infectious Diseases

Daniel Dornbusch, CEO of Excision BioTherapeutics, sits down with Neil to discuss his company’s efforts to develop CRISPR-based therapies to cure HIV and other viral infectious diseases.

continue reading >

The Bioverge Podcast: Finding Purpose in Building Early-Stage Companies

Khosla Ventures Partner Gwen Cheni sits down with Neil to talk her migration from Wall Street to early-stage TechBio companies, how that has shaped her investment approach in start-ups, and what emerging technologies excite her today.

continue reading >
Podcast

The Bioverge Podcast: Reengineering Healthcare and Medicine with Technology

Vineeta Agarwala, General Partner at Andreessen Horowitz and lead of the firm’s bio and health fund, sits down with Neil to discuss her investment process, how technology is transforming biotech and healthcare, and why she thinks drug development becoming more and more like software development.

Continue Reading >
Podcast

The Bioverge Podcast: Unlocking the Potential of Genetic Medicines

David Kirn, Co-Founder and CEO of 4DMT, sits down with Neil to discuss the limits of existing AAV vectors and how his company is using its Therapeutic Vector Evolution platform to invent customized vectors that allows it to take a disease specific approach to unlock the potential of genetic medicines.

Continue Reading >
News & Media

Neil Littman on The Scaling Up Podcast - Investing in the Future of Health

Neil is the Founder & CEO of Bioverge Ventures, an investment platform democratizing access to enable individuals to diversify their portfolio with private biotech and healthcare investments for the purposes of long-term wealth creation.

Continue Reading >
Health+Tech

JelikaLite: A Home-Based, Non-Invasive Therapy for Children with Autism

JelikaLite has developed the first home-based, non-invasive stimulation device for children with autism. Known as Cognilum, it combines a wearable neurostimulation and EEG-sensing device with an AI-driven data platform in an integrated system to analyze developmental trajectory and personalize future treatments in a feedback loop.

Continue Reading >
Podcast

The Bioverge Podcast: Making Medicines Affordable For Everyone

Peter Kolchinsky, Founder and Managing Director of RA Capital Management and Founder of the nonprofit No Patient Left Behind, sits down with Neil to discuss his book “The Great American Drug Deal,” policy fights over pricing, and his organization’s efforts to make medicines affordable for all Americans.

Continue Reading >
Podcast

The Bioverge Podcast: Unleashing the Power of Gene Therapy for a Broad Universe of Diseases

Kriya Therapeutics Co-Founder, Chairman, and CEO Shankar Ramaswamy sits down with Neil to discuss how the company is changing the way gene therapies are designed, developed, and manufactured in an effort to cut costs, accelerate the time to market, and expand the reach of gene therapy to a broad universe of disease.

Continue Reading >
Podcast

The Bioverge Podcast: A Bioinformatician Turned Investor Seeks to Transform Drug Development with Technology

Francisco Gimenez, Partner at 8VC, sits down with Neil to discuss how his background in data science and bioinformatics shapes his investment approach and the potential to transform drug development with technology.

Continue Reading >
Podcast

The Bioverge Podcast: A Rockstar Investor Who Backs Transformational Technologies

D.A. Wallach sits down with Neil to discuss his journey from recording artists to venture investors, his co-founding of Time BioVentures, and his vision from transforming biotechnology and healthcare with technology.

Continue Reading >
Podcast

The Bioverge Podcast: Harnessing CRISPR to Cure Infectious Diseases

Daniel Dornbusch, CEO of Excision BioTherapeutics, sits down with Neil to discuss his company’s efforts to develop CRISPR-based therapies to cure HIV and other viral infectious diseases.

Continue Reading >
Podcast

The Bioverge Podcast: Finding Purpose in Building Early-Stage Companies

Khosla Ventures Partner Gwen Cheni sits down with Neil to talk her migration from Wall Street to early-stage TechBio companies, how that has shaped her investment approach in start-ups, and what emerging technologies excite her today.

Continue Reading >
<< Previous